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Abstract: Annona emarginata (Schltdl.) H. Rainer, commonly known as “arachichú”, “araticú”,
“aratigú”, and “yerba mora”, is a plant that grows in Argentina. Infusions and decoctions are used
in folk medicine as a gargle against throat pain and for calming toothache; another way to use
the plant for these purposes is chewing its leaves. Extracts from bark, flowers, leaves, and fruits
from A. emarginata were subjected to antibacterial assays against a panel of Gram (+) and Gram (−)
pathogenic bacteria according to Clinical and Laboratory Standards Institute protocols. Extracts from
the stem bark and leaves showed moderate activity against the bacteria tested with values between
250–1000 µg/mL. Regarding flower extracts, less polar extracts (hexane, dichloromethane) showed
very strong antibacterial activity against methicillin-sensitive Staphylococcus aureus ATCC 25923 and
methicillin-resistant S. aureus ATCC 43300 with values between 16–125 µg/mL. Additionally, hexane
extract showed activity against Klebsiella pneumoniae (MIC = 250 µg/mL). The global methanolic
extract of the fruits (MeOHGEF) was also active against the three strains mentioned above, with MICs
values 250–500 µg/mL. Bioassay-guided fractionation of MeOHGEF led to the isolation of a new
main compound—(R)-2-(4-methylcyclohex-3-en-1-yl)propan-2-yl (E)-3-(4-hydroxyphenyl)acrylate
(1). The structure and relative configurations have been determined by means of 1D and 2D NMR
techniques, including COSY, HMQC, HMBC, and NOESY correlations. Compound 1 showed strong
antimicrobial activity against all Gram (+) species tested (MICs = 3.12–6.25 µg/mL). In addition, the
synthesis and antibacterial activity of some compounds structurally related to compound 1 (including
four new compounds) are reported. A SAR study for these compounds was performed based on the
results obtained by using molecular calculations.
Keywords: Annona emarginata; (R)-2-(4-methylcyclohex-3-en-1-yl)propan-2-yl (E)-3-(4-hydroxyphenyl)-
acrylate; antibacterial activity; Staphylococcus aureus; structure-activity relationships
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1. Introduction
Some genera from the family Annonaceae are an important natural source of products with
antifungal [1], bactericidal [2], pesticidal [3], herbicidal [4], antimalarial [5], antiprotozoal [6], and
cytostatic [7,8] activity, especially some chemically isolated components (primarily from seeds, leaves,
and bark). These compounds include flavonoids, alkaloids, and acetogenins. This family is widely
distributed in tropical and subtropical regions around the world in diversity of habitats (forests, scrub,
and grassland), with higher prevalence in rain forests. In general, representatives of the family are
shrubs, but it is also possible to find dwarf shrubs or small trees and, rarely, canopy trees or lianas
among them. The Annona genus comprises ca. 160 species from the tropical and subtropical areas,
from both hemispheres. Four species grow mainly in Argentina: Annona emarginata (Schltdl.) H.
Rainer (=Rollinia emarginata Schltdl.), A. neosalicifolia H. Rainer (=Rollinia salicifolia Schltdl.), A. nutans
(R.E. Fr.), and A. rugulosa (Schltdl.) H. Rainer. Previous studies related to ethnopharmacological use
have shown that the infusions and decoctions of the leaves of A. emarginata, commonly known
as “arachichú”, “araticú”, “aratigú”, and “yerba mora”, are used in folk medicine as a gargle
against throat pain and for calming the toothache. Another way it is used is by absorbing juice
produced by chewing the leaves [9,10]. Antiprotozoal [11] and antifeedant [12] properties have been
reported. Regarding its chemical composition, rolliniastatin-1, sylvaticin, squamocin, rollidecin B,
lirioresinol B, liriodenine [11]; vomifoliol, dehydrovomifoliol, blumenol C, loliolide, 7-epiloliolide,
vanillin, dihydroactinolide [12]; ursolic acid, oleanolic acid, 8-trans-p-coumaroyloxy-α-terpineol,
quercetin-3-O-α-L-arabinopyranosyl(1→2)-α-L-rhamnopyranoside [13]; alkaloids including two
aporphines (−)-anonaine, (−)-asimilobine and one benzyltetrahydroisoquinoline, (+)-reticuline [14],
and cyanogenic glycosides [15] have been previously isolated from its aerial parts. Resistance to
antimicrobials is a problem that increasingly threatens the world population [16]. The World Health
Organization established as “priority pathogens” those resistant to antibiotics, which include 12
families of bacteria most dangerous to human health, the so-called “superbugs”. Among them,
especially the threat posed by Gram (−) bacteria resistant to multiple antibiotics is highlighted. Among
the Gram (+) bacteria, methicillin-resistant Staphylococcus aureus (MRSA) [17] is one of the most
important. Thus, the development of new molecules, alternative strategies, and prevention and control
measures is necessary to avoid this problem.
The main objective of this work is to determine the antibacterial effect of different extracts of
A. emarginata (Schltdl.) H. Rainer, which is widely used in folk medicine in the northeast part of
Argentine. Another goal is to try to determine which active compound is responsible for such activity.
Thus, this work has been done in several stages. In the first step, the antimicrobial properties of
extracts of A. emarginata were studied, and the bioassay-guided isolation of its most active compound
was made. The compound was tested against an extended panel of both standardized and clinical
opportunistic pathogenic bacteria. The species were selected to include Gram (+) and Gram (−)
species of the most common human pathogens. Once the structure of the compound responsible for
the antibacterial activity was determined, some structurally related compounds were synthesized.
Finally, based on molecular calculations, we performed a study of the structure-activity relationships
of antibacterial compounds of the different series reported here.
2. Results and Discussion
2.1. Antimicrobial Evaluation of A. emarginata Extracts and Its Active Ingredient
The extracts from the stem bark and leaves of A. emarginata showed moderate activity against the
bacteria tested, with values between 250 and 1000 µg/mL (Table 1). Regarding flower extracts, the
less polar (hexane, dichloromethane) extracts, HFlE and DCMFlE, showed very strong antibacterial
activity against methicillin-sensitive S. aureus (MSSA) ATCC 25923 and methicillin-resistant S. aureus
(MRSA) ATCC 43300, with values between 16 and 125 µg/mL. Additionally, hexane extract showed
activity against Klebsiella pneumoniae (MIC = 250 µg/mL). The global methanolic extract from the fruits
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(MeOHGFE) was also active against the three strains mentioned above, with minimum inhibitory
concentration (MIC) values between 250–500 µg/mL. In order to identify bioactive compounds, a
bioassay-guided fractionation of the MeOHGFE was performed.
Table 1. Antibacterial activity (MIC (µg/mL)) of extracts of A. emarginata (Annonaceae).
Extracts
MIC (µg/mL)
MSSA MRSA E. coli ATCC25922 E. coli LM2 K. pneumoniae Salmonella sp.
Stem bark
HBE >1000 >1000 250 500 >1000 1000
DCMBE 1000 >1000 500 >1000 1000 250
EtAcOBE 500 1000 500 500 >1000 500
MeOHBE 500 500 1000 1000 >1000 1000
Leaves
HLE 500 250 >1000 >1000 >1000 500
DCMLE 500 500 >1000 1000 1000 500
EtAcOLE 500 500 >1000 >1000 250 500
MeOHLE >1000 >1000 500 500 500 500
Flowers
HFlE 125 125 >1000 >1000 250 1000
DCMFlE 62.5 16 >1000 >1000 1000 >1000
EtAcOFlE 250 250 1000 >1000 500 >1000
MeOHFlE >1000 >1000 1000 1000 >1000 >1000
Fruits MeOHGFE 500 500 >1000 >1000 250 >1000
cefotaxime 0.5 0.5 1.9 0.5 15 12.5
HBE: hexane bark extract; DCMBE: dichloromethane bark extract; EtOAcBE: ethyl acetate bark extract; MeOHBE:
methanol bark extract; HLE: hexane leaf extract; DCMLE: dichloromethane leaf extract; EtOAcLE: ethyl acetate leaf
extract; MeOHLE: methanol leaf extract; HFlE: hexane flower extract; DCMFlE: dichloromethane flower extract;
EtOAcFlE: ethyl acetate flower extract; MeOHFlE: methanol flower extract; MeOHGFE: methanol global fruit extract.
Tables 2 and 3 show the antimicrobial activity of fractions and subfractions of the MeOHGFE.
Fraction F3 displayed the strongest antibacterial activity (Table 2) against MSSA, MRSA, Escherichia coli
ATCC 25922 (MIC = 500 µg/mL), and K. pneumoniae (MIC = 125 µg/mL). To gain further information
about their activity spectrum against Gram (+) strains, we added a panel of clinical isolates obtained
from human patients (coagulase negative Staphylococcus aureus 502, Streptococcus pyogenes and
Streptococcus agalactiae) (Tables 3 and 4). Fraction F3 was further percolated on Sephadex LH-20
affording 5 subfractions (I–V). One of them, subfraction FIV, showed strong antibacterial activity
with MIC = 16 µg/mL against all the Gram (+) bacteria tested, except for coagulase negative S.
aureus 502 (MIC = 31.2 µg/mL), Escherichia coli LM2 (MIC = 125 µg/mL), and K. pneumoniae (MIC
= 250 µg/mL, respectively). On the basis of the previous results, subfraction FIV was successively
purified by Sephadex LH-20 and silica gel column, affording the main antibacterial compound 1
(Figure 1). As we expected, compound 1 showed stronger antimicrobial activity against both Gram (+)
ATCC strains with MICs = 3.12–6.25 µg/mL, and the expanded panel strains were also sensitive to this
compound with MICs value equal 3.12 µg/mL (Table 4). In contrast, compound 2 (see below) was
practically inactive.
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Table 2. Antibacterial activity (MIC (µg/mL)) of fractions F1-F6 from MeOHGEF.
Extracts
MIC (µg/mL)
MSSA MRSA E. coli ATCC25922 E. coli LM2 K. pneumoniae Salmonella sp.
MeOHGFE 500 500 >1000 >1000 250 >1000
MeOHGFE
Fractions
F1 >1000 >1000 >1000 >1000 >1000 >1000
F2 500 250 >1000 >1000 >1000 >1000
F3 500 500 500 >1000 125 >1000
F4 1000 1000 1000 125 1000 >1000
F5 500 500 1000 250 125 >1000
F6 250 500 250 250 >1000 >1000
cefotaxime 0.5 0.5 1.9 0.5 15 12.5
MeOHGFE: methanol global extract fruit; F1 (200 mg; hex 100%), F2 (115 mg; 50:50% H:DCM), F3 (1200 mg; 90:10%
DCM:EtOAc), F4 (187.7 mg 80:20% DCM:EtOAc), F5 (155 mg; 70:30% DCM:EtOAc), and F6 (137 mg; EtOAc100%).
Table 3. Antibacterial activity (MIC (µg/mL)) of subfractions FI-V from F3.
Extracts
MIC (µg/mL)
MSSA MRSA SA SP SAG EC ELM KP Ssp
MeOHGFE Fraction F3 500 500 500 250 250 500 >1000 125 >1000
F3
subfractions
Subfraction I >250 >250 >250 >250 >250 >250 >250 >250 >250
Subfraction II >250 >250 >250 >250 >250 250 >250 >250 >250
Subfraction III >250 >250 >250 >250 >250 >250 250 >250 >250
Subfraction IV 16 16 31.2 16 16 >250 125 250 >250
Subfraction V 62.5 62.5 62.5 62.5 62.5 >250 >250 >250 >250
cefotaxime 0.5 0.5 0.5 0.25 0.25 1.9 0.5 15 12.5
MSSA = methicillin-sensitive Staphylococcus aureus ATCC 25923, MRSA = methicillin-resistant Staphylococcus aureus
ATCC 43300, SA = coagulase negative Staphylococcus aureus 502, SP = Streptococcus pyogenes, SAG = Streptococcus
agalactiae, EC = Escherichia coli ATCC 25922, ELM = Escherichia coli LM2, KP = Klebsiella pneumoniae, Ssp =
Salmonella sp.
Table 4. Antibacterial activity (MIC [µg/mL]) of compound 1 (isolated from subfraction FIV) and
compounds 2–7 obtained by synthesis.
Comp.
MIC (µg/mL)
MSSA MRSA SA SP SAG EC ELM KP
1 4 6.25 3.12 3.12 3.12 >50 50 50
2 >50 >50 >50 >50 >50 >50 >50 >50
3 50 50 50 50 50 >50 >50 >50
4 >50 >50 >50 >50 >50 >50 >50 >50
5 50 >50 25 25 50 >50 >50 >50
6 25 50 50 50 50 >50 25 >50
7 12.5 50 12.5 25 12.5 >50 12.5 >50
CEF 0.5 0.5 0.5 0.25 0.25 1.9 0.5 15
MSSA = methicillin-sensitive Staphylococcus aureus ATCC 25923, MRSA = methicillin-resistant Staphylococcus aureus
ATCC 43300, SA = coagulase negative Staphylococcus aureus 502, SP = Streptococcus pyogenes, SAG = Streptococcus
agalactiae, EC = Escherichia coli ATCC 25922, ELM = Escherichia coli LM2, KP = Klebsiella pneumoniae, CEF = cefotaxime.
Molecules 2018, 23, x; doi: 4 of 13 
 
Table 3. Antibacterial activity (MIC (µg/mL)) of subfractions FI-V from F3. 
Extracts 
MIC (µg/mL) 
MSSA MRSA SA SP SAG EC ELM KP Ssp 
MeOHGFE fraction F3 500 500 500 250 250 500 >1000 125 >1000 
F3 subfractions 
Subfraction I >250 >250 >250 >250 >250 >250 >250 >250 >250 
Subfraction II >250 >250 >250 >250 >250 250 >250 >250 >250 
Subfraction III >250 >250 >250 >250 >250 >250 250 >250 >250 
Subfraction IV 16 16 31.2 16 16 >250 125 250 >250 
Subfraction V 62.5 62.5 62.5 62.5 62.5 >250 >250  >250 
cefotaxime 0.5 0.5 0.5 0.25 0.25 1.9 0.5 15 12.5 
MSSA = methicillin-sensitive Staphylococcus aureus ATCC 25923, MRSA = methicillin-resistant 
Staphylococcus aureus ATCC 43300, SA = coagulase negative Staphylococcus aureus 502, SP = 
Streptococcus pyogenes, SAG = Streptococcus agalactiae, EC = Escherichia coli ATCC 25922, ELM = 
Escherichia coli LM2, KP = Klebsiella pneumoniae, Ssp = Salmonella sp. 
Table 4. Antibacterial activity (MIC [µg/mL]) of compound 1 (isolated from subfraction FIV) and 
compounds 2–7 obtained by synthesis. 
Comp. 
MIC (µg/mL) 
MSSA MRSA SA SP SAG EC ELM KP 
1 4 6.25 3.12 3.12 3.12 >50 50 50 
2 >50 >50 >50 >50 >50 >50 >50 >50 
3 50 50 50 50 50 >50 >50 >50 
4 >50 >50 >50 >50 >50 >50 >50 >50 
5 50 >50 25 25 50 >50 >50 >50 
6 2  50 50 50 50 >50 25 >50 
7 12.5 50 12.5 25 12.5 >50 12.5 >50 
CEF 0.5 0.5 0.5 0.25 0.25 1.9 0.5 15 
MSSA = methicillin-sensitive Staphylococcus aureus ATCC 25923, MRSA = methicillin-resistant 
Staphylococcus aureus ATCC 43300, SA = coagulase negative Staphylococcus aureus 502, SP = 
Streptococcus pyogenes, SAG = Streptococcus ag lactiae, EC  Escherichia coli ATCC 25922, ELM = 
Escherichia coli LM2, KP = Klebsiella pneumoniae, CEF = cefotaxime. 
 
Figure 1. Structural features of compounds studied. Torsional angles are shown for compound 1. 
2.2. Natural Lead Structure 
The strongest antimicrobial subfraction IV was successively chromatographed on silica gel to 
afford pure compound 1, which was identified by its spectroscopic data, including 1H, 13C-NMR, and 
HR-EIMS spectra as (R)-2-(4-methylcyclohex-3-en-1-yl)propan-2-yl (E)-3-(4-hydroxyphenyl)acrylate 
(1), see Figure 1 and spectra in Supplementary material. The relevant NOESY correlations (Figure 2), 
a strong positive Cotton effect observed in the CD spectrum and spectroscopic data, which are in 
partial agreement with those previously published for the compound 9-trans-p-coumaroyloxy-α-
terpineol, isolated from Haplopappus taeda [18], support the structure and absolute configuration 
proposed in Figure 2. In addition, (DFT) (B3LYP/6-31G (d)) calculations suggest that this structure is 
0.46 Kcal/mol more stable than its isomeric form, giving additional support to the experimental data. 
Figure 1. Structural features of compounds studied. Torsional angles are shown for compound 1.
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2.2. Natural Lead Structure
The strongest antimicrobial subfraction IV was successively chromatographed on silica gel to
afford pure compound 1, which was identified by its spectroscopic data, including 1H, 13C-NMR, and
HR-EIMS spectra as (R)-2-(4-methylcyclohex-3-en-1-yl)propan-2-yl (E)-3-(4-hydroxyphenyl)acrylate
(1), see Figure 1 and spectra in Supplementary Material. The relevant NOESY correlations (Figure 2), a
strong positive Cotton effect observed in the CD spectrum and spectroscopic data, which are in partial
agreement with those previously published for the compound 9-trans-p-coumaroyloxy-α-terpineol,
isolated from Haplopappus taeda [18], support the structure and absolute configuration proposed in
Figure 2. In addition, (DFT) (B3LYP/6-31G (d)) calculations suggest that this structure is 0.46 Kcal/mol
more stable than its isomeric form, giving additional support to the experimental data.Molecules 2018, 23, x; doi: 5 of 13 
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Then, compounds 3–5 were synthesized, in which the first moiety of compound 1 was 
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(rings A and B) of the quinoline scaffold (see Figure 1). Styrylquinoline derivatives 3 and 4 were 
prepared by condensation of the quinoline derivative with an appropriate aldehyde in a mixture of 
acetic anhydride/acetic acid. 2-[2-(4-Hydroxyphenyl)vinyl]quinolin-8-ol (5) was hydrolysed in 
methanol with K2CO3, then precipitated by concentrated HCl and crystallized from ethanol, see 
Scheme 2. 
Figure 2. Key NOESY correlations of compound 1.
2.3. Synthetic Analogues
Observing the structure of compound 1, it is interesting to note that the moiety having
the aromatic ring corresponds to a structure very similar to that of p-coumaric and caffeic
acids. Previously, it was reported that analogues of p-coumaric and caffeic acids have
significant antibacterial and antifungal activities [19,20]. In fact, several phenolic compounds
and derivatives possessing antifungal effects have been reported. For example, gallic acid
has been reported to prevent aflatoxin biosynthesis by Aspergillus flavus [21]. Two compounds
of natural origin, 1-(3′-methoxypropanoyl)-2,4,5-trimethoxybenzene and 2-(2Z)-(3-hydroxy-3,7-
dimethylocta-2,6-dienyl)-1,4-benzenediol, isolated from the root bark of Cordia alliodora, have been
also reported as antifungal and larvicidal compounds [22]. In turn, Kim et al. [23] reported antifungal
effects of several phenolic compounds, including cinnamic, m-coumaric, p-coumaric, and caffeic acids;
therefore, the significant antibacterial activity found for compound 1 should not be so surprising.
At this stage of the study, efforts were focused on finding new compounds structurally related
to lead compound 1 that may have antibacterial activity. First, (R)-2-(4-methylcyclohex-3-en-1-yl)-
propan-2-yl (E)-3-(4-ethoxyphenyl)acrylate (2) was obtained by a simple modification of compound 1,
see Scheme 1. Interestingly, compound 2 was devoid of antibacterial activity displaying MICs values
>50 µg/mL. It should be noted that the only structural difference between compounds 1 and 2 is the
ethylation of the hydroxyl group of compound 1.
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Then, compounds 3–5 were synthesized, in which the first moiety of compound 1 was maintained,
while the second part (4-hydroxyphenyl) of the molecule was replaced by a fused ring (rings A
and B) of the quinoline scaffold (see Figure 1). Styrylquinoline derivatives 3 and 4 were prepared
by condensation of the quinoline derivative with an appropriate aldehyde in a mixture of acetic
anhydride/acetic acid. 2-[2-(4-Hydroxyphenyl)vinyl]quinolin-8-ol (5) was hydrolysed in methanol
with K2CO3, then precipitated by concentrated HCl and crystallized from ethanol, see Scheme 2.Molecules 2018, 23, x; doi: 6 of 13 
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Scheme 2. Synthesis of compound 3–5. Reagents and conditions: (a) Ac2O, 80% AcOH, 18 h at 130 ◦C,
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After synthesis of compounds 3–5, their potential antibacterial activities were evaluated. While
compound 5 showed moderate antibacterial activity, compounds 3 and 4 were inactive. It is interesting
to note that the only structural difference between compound 5 and compounds 3 and 4 is the
replacement of the OH group by OAc and OCH3, respectively. These results are in accord with those
obtained for compounds 1 and 2, since the ethylation of the OH group of 1 produced significant loss of
antibacterial activity. From these results, it appears that the presence of a proton donor group in the
ring A of these compounds could play an important role in the antibacterial effect, e.g., compare Gonec
et al. [24] with Kos et al. [25,26]. In order to understand better this behaviour, a conformational and
electronic study was performed for these compounds with the aim to determine their stereo-electronic
characteristics. Details about the type of molecular calculations and the methodology used are
explained in the Section 3.4. In addition, details about the conformational analysis of the compounds
are also given in the same section. Knowledge of the stereo-electronic attributes and properties of these
compounds will contribute significantly to the elucidation of the structural requirements to produce
antibacterial activity. Molecular electrostatic potentials (MEP) are of particular value, because they
allow the visualization and assessment of the capacity of a molecule to interact electrostatically with
a putative-binding site [27–29]. Thus, once the conformational behaviours of compounds reported
here had been analysed, an electronic study of their respective preferred conformations by using
Electrostatic Potentials Maps (EPMs) was performed. Figure 3 gives the Molecular Electrostatic
Potentials (MEP) obtained for compounds 1 and 3. The MEP obtained for compound 1 (Figure 3a)
exhibit three characteristic regions: a clear minimum value (deep red zone with V(r)min ≈ −0.1559
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el/au3) in the vicinity of the OH group of the ring A, a positive region (deep blue zone with V(r)max
≈ 0.20 el/au3) located in the linker chain, and an extended hydrophobic zone (deep and light green
zone with an almost neutral potential V(r)med ≈ −0.0011 el/au3) in the zone near to the ring B.Molecules 2018, 23, x; doi: 7 of 13 
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It is interesting to note that the MEP of compound 3 (Figure 3b) is similar to that obtained for 1.
However, for compound 3, both the most electronegative zone (zone with red and orange tones) and
the electropositive part of the molecule (area with bluish tonalities) are significantly more tenuous
with values of V(r)min ≈ −0.120 el/au3 and V(r)max ≈ 0.110 el/au3, respectively. These results are in
agreement with the experimental data, considering that compound 3 displayed lower antibacterial
activity than compound 1.
A series of carboxanilides with antimycobacterial properties, including
6-hydroxy-N-phenylnaphthalene-2-carboxamide (6) and 6-hydroxy-N-(3-trifluoromethylphenyl)
naphthalene-2-carboxamide (7) (see Figure 1), was reported recently [25]. They were prepared
according to Scheme 3 by modified microwave-assisted synthesis in one step with excellent yields. At
first, the carboxyl group was activated with phosphorus trichloride. The final amide was immediately
formed by aminolysis of acyl chloride by a ring-substituted aniline in dry chlorobenzene. All the crude
target compounds were recrystallized from ethanol.
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It should be noted that these compounds are naphthalene analogues (carbon isosteres) of the
quinoline scaffold, i.e., they also possess fused rings in their structure (rings A and B), which gives a
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certain structural similarity to the first portion of compound 1. Next, a conformational and electronic
study of compounds 6 and 7 was performed, and the results were compared with those obtained for
the rest of compounds studied here. Figure 3c indicates that compound 6 displays MEP that are very
similar to those obtained for compound 1 (compare Figure 3a,c). In this case, the values obtained for
V(r)max and V(r)min are very similar to those observed in compound 1. A very similar result was
obtained for compound 7. Based on these results, it was decided to test these compounds as potential
antibacterial agents. Compounds 6 and 7, especially compound 7, showed significant antibacterial
effects against the different strains studied here (Table 4). These experimental results fully agree with
the molecular calculations and give additional support to the proposed pharmacophoric pattern. Once
again, the presence of a proton donor group at ring A appears to be an essential structural requirement
for antibacterial effect.
3. Materials and Methods
3.1. Extractions and Isolation
3.1.1. General Methods
1H and 13C-NMR spectra were recorded on a High Resolution Spectrometer Advance 400
(working frequency 400 MHz and 100 MHz, respectively) at ambient temperature in CDCl3 (Aldrich,
St. Louis, MO, USA). Carbon spectra assignments are supported by DEPT-135 spectra, 13C-1H (HMQC)
and 13C-1H (HMBC), and NOESY correlations. High-resolution mass spectrums were measured on
Bruker Micro TOF Q II equipment (Bruker, Karlsruhe, Germany), operated with an ESI source in the
positive mode. Optical rotations were measured with a Jasco polarimeter DIP-1000 P-1010 34 (Jasco,
Easton, MD, USA). The CD (Circular Dichroism) and UV-VIS spectra of methanol solutions of 1 and 2
were recorded simultaneously using a Jasco J-810 spectropolarimeter, model J-810 150S and a 100 lm
quartz cuvette with resolution 1 nm, time constant 1 s, scan speed 100 nm/min, and 3 accumulations,
employing standard sensitivity and a measurement range of 700–190 nm.
3.1.2. Plant Material
The aerial parts (leaves, flowers, and fruits) of A. emarginata were collected in San Cosme, province
of Corrientes (Argentina) at 27.36667 lat. S; 58.51667 long. W, in the summer of 2013 and were
authenticated by Dra. Elisa Petenatti and L.A. Del Vitto. A voucher specimen (L.A. Del Vitto & E.M.
Petenatti # 9490) has been deposited at the Herbarium, National University of San Luis, Argentina.
3.1.3. Preparation of Extracts
Finely ground A. emarginata fruits (100 g) were extracted at room temperature using methanol
MeOH (200 mL × 3-fold × 96 h each), filtered and concentrated under reduced pressure to afford
the corresponding crude global methanolic extract (MeOHGFE; 17.7 g, yield 17.7% w/w). Dried and
finely ground A. emarginata flowers (100 g) were successively extracted at room temperature (200
mL × 3-fold × 96 h, each 3 × 24 h) with hexane (H), dichloromethane (DCM), ethyl acetate (EtOAc),
and methanol (MeOH). Then, solvents were evaporated under vacuum to give flower extracts HFlE,
DCMFlE, EtOAcFlE, and MeOHFlE with yields (w/w) of 4.3%, 1.9%, 0.66%, and 5.9%, respectively.
Finely ground dried A. emarginata stem bark (100 g) was successively extracted at room temperature
(200 mL × 3-fold × 96 h, each 3 × 24 h) with H, DCM, EtOAc, and MeOH. The solvents were
evaporated under vacuum to afford bark extracts HBE, DCMBE, EtOAcBE, and MeOHBE with yields
(w/w) of 0.92%, 0.27%, 0.34%, and 4.23%, respectively. Finely ground dried A. emarginata leaves (100 g)
were successively extracted at room temperature (200 mL× 3-fold× 96 h, each 3× 24 h) with H, DCM,
EtOAc, and MeOH. Then, solvents were evaporated under vacuum to produce leaf extracts HLE,
DCMLE, EtOAcLE, and MeOHLE, affording 0.63%, 1.54%, 0.75%, and 1.02% yield (w/w), respectively.
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3.1.4. Bioassay-Guided Fractionation of Annona emarginata Fruit Extracts (MeOHGFE)
MeOHGFE (11 g) was applied onto a column (column length 70 cm, i.d. 5 cm) containing silica
gel (0.063–0.2 mesh, Merck 60, Merck, Darmstadt, Germany) and eluted with H, DCM, and EtOAc
gradients (100% H to 100% EtOAc). Six fractions of 1 L each were obtained, which concentrated
under reduced pressure to afford F1 (200 mg; H 100%), F2 (115 mg; 50:50% H/DCM), F3 (1200 mg;
90:10% DCM/EtOAc), F4 (187.7 mg 80:20% DCM/EtOAc), F5 (155 mg; 70:30% DCM/EtOAc), and
F6 (137 mg; EtOAc 100%) fractions. Fractions F1–F6 were tested for antimicrobial activity. Fraction
F3 (1100 mg) permeated through Sephadex LH-20 (column length 23 cm, i.d. 4 cm; petroleum ether
(PE)/MeOH/DCM 2:1:1). Some 21 fractions of 15 mL each were obtained. After TLC comparison (silica
gel, PE/EtOAc 8:2) as the mobile phase, detection under UV light and spraying with p-anisaldehyde
sulfuric acid, the fractions with similar TLC patterns were combined as follows: I (477 mg), II (142 mg),
III (98 mg), IV (295 mg), and V (84 mg).
3.1.5. Isolation and Characterization of (R)-2-(4-Methylcyclohex-3-en-1-yl)propan-2-yl
(E)-3-(4-hydroxyphenyl)acrylate (1)
Separation of the fraction IV (295 mg) using column chromatography on silica gel (column length
40 cm, internal diameter 2 cm; 50 g silica gel 0.063–0.2 mesh, Merck 60); (100% H to 100% EtOAc)
provided 200 mg of pure compound 1: oil; [α]23D + 29 (c = 0.17 g/100 mL, CHCl3),
1H-NMR (400 MHz,
CDCl3) δ 1.50 (s, 3H, H-9′), 1.53 (s, 3H, H10′), 1.67 (s, 3H, H-7′), 1.85–1.35 (m, 2H, H-3′), 2.12 (m, 1H,
H-4′), 2.16–1.86 (m, 4H, H-2′, H-5′), 5.39 (s, 1H, H-6′), 6.22 (d, J = 16 Hz, 1H, H-8), 6.85 (d, J = 8Hz, 2H,
H-3 and H-5), 7.38 (d, J = 8 Hz, 2H, H-2 and H-6), 7.51 (d, J = 16 Hz, 1H, H-7); 13C-NMR (100 MHz,
CDCl3) δ 23.3 CH3, δ 23.4 CH3, 23.5 CH3, 24.0 CH2, 26.5 CH2, 30.9 CH2, 42.8 CH (C-4′), 85.2 C (C-8′),
115.9 CH ×2 (C-3 and C-5), 117.2 CH (C-8), 120.3 CH (C-6′), 127.0 (C-1), 129.9 CH ×2 (C-2 and C-6),
134.0 (C-1′), 143.8 (C-7), 158.4 (C-4), 167.8 C (C=O), HR-EIMS 323.1618, (calcd for C19H24O3 (M + Na)
323.1618). (See spectra in Supplementary Material).
3.2. Synthesis
3.2.1. General Methods
All of the reagents were purchased from Aldrich. Kieselgel 60, 0.040–0.063 mm (Merck,
Darmstadt, Germany) was used for the column chromatography. TLC experiments were performed
on alumina-backed silica gel 40 F254 plates (Merck, Darmstadt, Germany). The plates were illuminated
under UV (254 nm) and evaluated in iodine vapour. The melting points were determined on an
Optimelt MPA-100 apparatus (SRS, Stanford, CA, USA). The purity of the final compounds was
checked using HPLC. Detection wavelengths of 210 and 250 nm were chosen for detection. The purity
of individual compounds was determined from the area peaks in the chromatogram of the sample
solution in order to ensure >95% purity. All 1H-NMR spectra were recorded on a Bruker AM-400
(400 MHz for 1H and 101/126 MHz for 13C), BrukerBioSpin Corp., Rheinstetten, Germany. Chemical
shifts are reported in ppm (δ) against the internal standard, Si(CH3)4. Easily exchangeable signals
were omitted when they were diffused. Signals are designated as follows: s, singlet; d, doublet; dd,
doublet of doublets; m, multiplet. The high-resolution mass spectra of compounds 3–5 were measured
using a high-performance liquid chromatograph Dionex UltiMate®3000 (Thermo Scientific, Waltham,
MA, USA) coupled with a LTQ Orbitrap XLTM Hybrid Ion Trap-Orbitrap Fourier Transform Mass
Spectrometer (Thermo Scientific) with injection into HESI II in the positive mode.
3.2.2. Synthesis of (R)-2-(4-Methylcyclohex-3-en-1-yl)propan-2-yl (E)-3-(4-ethoxyphenyl)acrylate (2)
In a Schlenk tube equipped with a magnetic stirrer, t-BuOK (0.118 mmol) was added to 2 mL
of degassed DMSO under nitrogen atmosphere. After 10 min, when no more solid was present,
compound 1 (0.098 mmol) was added. The reaction mixture was stirred for 30 min until the formation
of the corresponding ions. The reaction was then quenched by adding excess ethyl iodide (0.196 mmol)
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to obtain compound 2. The solution was extracted with ethyl acetate and water. The organic extract
was analysed by GC-MS. The reaction was then quenched by adding excess ethyl iodide (0.196 mmol)
to obtain a brown oil that was purified by column chromatography on silica gel (column length 40
cm, internal diameter 2 cm; 50 g silica gel (0.063–0.2 mesh, Merck 60) using a solvent gradient (100%
PE to 100% EtOAc) to afford 110 mg of pure compound 2: oil (yield 95%); [α]23D + 23 (c = 0.11 g/100
mL, CHCl3), 1H-NMR (400 MHz, CDCl3) δ 1,42 (t, 3H, CH3 ethyl), 1.50 (s, 3H, H-9′), 1.53 (s, 3H, H10′),
1.65 (s, 3H, H-7′), 1.85–1.35 (m, 2H, H-3′), 2.12 (m, 1H, H-4′) 2.16–1.86 (m, 4H, H-2′, H-5′), 4.05 (q, 2H,
CH2 ethyl), 5.39 (s, 1H, H-6′), 6.23 (d, J = 16 Hz, 1H, H-8), 6.87 (d, J = 8Hz, 2H, H-3, H-5), 7.44 (d J = 8
Hz, 2H, H-2, H-6), 7.52 (d, J = 16 Hz, 1H, H-7); 13C-NMR (100 MHz, CDCl3) δ 14.7 CH3 (ethyl) 23.3
CH3, 23.4 CH3, 23.5 CH3, 24.0 CH2, 26.5 CH2, 30.9 CH2, 42.7 CH (C-4′), 63.5 (s, 2 H, CH2 ethyl), 84.9 C
(C-8′), 114,7 CH (C-3, C-5), 117.6 CH (C-8), 120.4 CH (C-6′), 127.2 (C-1), 129.6 CH (C-2 and C-6), 134.0
(C-1′), 143.3 (C-7), 160.0 CH (C-4), 168.9 C (C=O), HREIMS 351.1935, (calcd for C21H28O3 (M + Na)
351.1931). (See spectra in Supplementary Material).
3.2.3. General Synthesis of Styrylquinoline Derivatives 3–5
The appropriate quinoline derivative (2.5 mmol) in acetic anhydride with 80% acetic acid was
thoroughly mixed with one equivalent aldehyde and heated in an inert gas atmosphere (N2) at 130 ◦C
for 18 h. Then, the mixture was evaporated to dryness, and a solid was recrystallized from ethanol.
The appropriate styrylquinoline derivative (2.5 mmol) in methanol was thoroughly mixed with 2.5
equivalent K2CO3 at room temperature for 2 h. Then, concentrated HCl was added, and the resulting
precipitate was filtered and washed with H2O. The crude product was crystallized from ethanol.
2-[2-(4-Methoxyphenyl)vinyl]quinolin-8-yl acetate (3): yield 20%, light brown solid, m.p. 97−100 ◦C;
HPLC purity 95.82%; 1H-NMR (400 MHz, DMSO-δ6) δ 8.38 (d, J = 8.6 Hz, 1H), 7.90–7.82 (m, 2H), 7.78
(d, J = 16.3 Hz, 1H), 7.70 (d, J = 8.5 Hz, 2H), 7.57–7.47 (m, 2H), 7.30 (d, J = 16.3 Hz, 1H), 7.02 (d, J =
8.5 Hz, 2H), 3.82 (s, 3H), 2.50 (s, 3H); 13C-NMR (126 MHz, DMSO-δ6) δ 172.49, 160.23, 154.26, 153.29,
138.60, 136.84, 134.57, 129.58, 129.39, 129.11, 127.97, 127.24, 126.14, 122.09, 121.25, 118.02, 114.87, 111.58,
55.69, 21.52. HR-MS: for C20H18NO3 [M + H]+ calculated 320.1281 m/z, found 320.1284 m/z.
2-[2-(4-Acetoxyphenyl)vinyl]quinolin-8-yl acetate (4): yield 67%, yellow solid, m.p. 157–159 ◦C; HPLC
purity 95.83%; 1H-NMR (400 MHz, CDCl3) δ 8.15 (dd, J = 8.5, 5.1 Hz, 1H), 7.73–7.60 (m, 5H), 7.55–7.37
(m, 3H), 7.19–7.12 (m, 2H), 2.58 (s, 3H), 2.35 (s, 3H); 13C-NMR (101 MHz, CDCl3) δ 169.84, 169.33,
155.65, 150.91, 147.38, 140.94, 136.41, 134.25, 133.71, 131.21, 129.10, 128.60, 128.32, 125.75, 125.54, 121.95,
121.68, 120.19, 21.17, 21.03. HR-MS: for C21H18NO4 [M + H]+ calculated 348.1230 m/z, found 348.1239
m/z.
2-[2-(4-Hydroxyphenyl)vinyl]quinolin-8-ol (5): yield 63%, orange solid, m.p. 156–157 ◦C; HPLC purity
98.38%; 1H-NMR (400 MHz, DMSO-δ6) δ 11.81 (s, 1H), 10.38 (s, 1H), 8.84 (d, J = 8.9 Hz, 1H), 8.42 (d, J =
8.9 Hz, 1H), 8.22 (d, J = 16.2 Hz, 1H), 7.79 (d, J = 16.3 Hz, 1H), 7.67–7.56 (m, 4H), 7.47 (dd, J = 6.1, 2.6
Hz, 1H), 6.95 (d, J = 8.6 Hz, 2H); 13C-NMR (126 MHz, DMSO-δ6) δ 161.19, 153.30, 148.85, 144.14, 143.99,
143.72, 130.85, 129.57, 128.20, 126.55, 119.16, 118.74, 116.83, 116.50. HR-MS: for C17H13NO2 [M + H]+
calculated 264.1019 m/z, found 264.1028 m/z.
6-Hydroxy-N-phenylnaphthalene-2-carboxamide (6) and 6-hydroxy-N-(3-trifluoromethylphenyl)-
naphthalene-2-carboxamide (7) were synthesized and characterized recently [25].
3.3. Antibacterial Activity
For the antibacterial evaluation, methicillin-sensitive Staphylococcus aureus ATCC 25923,
methicillin-resistant S. aureus ATCC 43300, Escherichia coli ATCC 25922, and clinical isolates from
human patients—coagulase negative Staphylococcus aureus 502, Streptococcus pyogenes, Streptococcus
agalactiae, Escherichia coli LM2, Salmonella sp. and Klebsiella pneumoniae—provided by Laboratorio de
Microbiologia, Hospital Marcial Quiroga, San Juan, Argentina, were used.
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Minimal inhibitory concentration (MIC) values were determined using the broth microdilution
method according to the protocols of the Clinical and Laboratory Standards Institute [30]. The assay
was executed in Mueller–Hinton broth (MHB), using strains 24 h old. The inoculum employed was
1–5 × 105 CFU/mL. Stock solutions of extracts in DMSO (50 mg/mL) were diluted to give serial
2-fold dilutions that were added to each medium to obtain final concentrations ranging from 1000
to 1 µg/mL. Stock solutions of compounds in DMSO (5 mg/mL) were diluted to give serial 2-fold
dilutions that were added to each medium to obtain final concentrations ranging from 50 to 1 µg/mL.
The final concentration of DMSO in the assay did not exceed 1%. Cefotaxime Argentia® (Bristol-Myers
Squibb, Buenos Aires, Argentina) was included in the assays as a positive control, while MHB and
DMSO (1%) were used as negative controls. The plates were incubated for 24 h at 37 ◦C. Activity was
evaluated at 620 nm using a Multiskan™ FC Microplate Photometer (Thermo Fisher Scientific, Vantaa,
Finland). The MIC values were defined as the lowest extract concentrations showing no bacterial
growth after the incubation time. Tests were done in triplicate.
3.4. Conformational and Electronic Study
All calculations were carried out using the Gaussian 09 program (Gaussian, Wallingford, CT,
USA) [31]. The search for low-energy conformations on the potential energy surface for compounds
1, 3, 6, and 7 was carried out by using combined ab initio (RHF/3-21G) and density functional
theory (DFT) (B3LYP/6-31G(d)) calculations. Final DFT geometries were obtained from the geometry
optimisation jobs. Minima were characterized through harmonic frequency analysis calculated at DFT
level. Correlations effects were included using DFT and the functional of Lee [32] as proposed and
parameterized by Becke [33,34] (RB3LYP) and 6-31G (d) basis set. Compound 1 looks like a relatively
simple conformational problem, in which three torsional angles (φ1, φ2, and φ3, Figure 1) are main
rotations in this molecule. Our calculations predict that the torsional angle φ1 possesses only two
possible quasi-planar conformations: one of them near to 0◦, and the opposite position giving values
near to 180◦. The energy barrier obtained for this rotation is more than 10 Kcal/mol, suggesting a
significantly restricted torsional angle (see Figure S1 in Supplementary Material). It should be noted
that the cis form possesses about 1 Kcal/mol above the trans form; therefore, the conformational
analysis of compound 1 considering φ1 near to 180◦ was performed. The orientations of the ring
B are mainly described by the dihedral angles φ2 and φ3, and probably the most comprehensive
computational method to evaluate how the local energy minima and the transition states are linked
together requires an exploration of the complete potential energy surface (PES) generated by φ2 vs.
φ3. This PES was calculated using a 12 × 12 grid generated by rotating through φ2 and φ3 in 30◦
increments from −180 to 180◦. At each point, a complete geometry optimization was performed with
φ2 and φ3 frozen at their respective grid values. The graphical presentation of the PES was generated
using the program AXUN 5.0 (MathSoft, Cambridge, MA, USA), plotting the total energy values as a
dependent variable generated by double scans over independent variables φ2 and φ3. The optimum
coordinates of φ2 and φ3 for all possible minima were then visually estimated from the level contours
diagrams (Figure S2 in Supplementary Material). Five different conformations (conformations 1–5)
were obtained for 1; such low-energy conformers might be well appreciated in this surface. The global
minimum (conformer 1) corresponds to a partially extended form (see Table S1 in Supplementary
Material). On the other hand, the conformational analysis suggests planar forms as energetically
preferred structures for compounds 3, 6, and 7. This is an expected result, considering the structural
characteristics of their connecting chains. In compound 3, it is a highly delocalized system, while in
compounds 6 and 7, it is a peptide bond. The electronic study of compounds 1, 3, 6, and 7 was carried
out using molecular electrostatic potentials (MEP) [27]. MEP have been shown to provide reliable
information both on the interaction sites of the molecules with point charges and on the comparative
reactivities of such sites [28,29]. These MEP were calculated using B3LYP/6-311G (d,p) wave functions
from the MOLEKEL 4.0. program (CSCS, Manno, Switzerland) [35].
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4. Conclusions
Strong antibacterial activities found for some of the extracts studied here fully justify the use of
infusions and decoctions of Annona emarginata (Schltdl.) H. Rainer in folk medicine for the treatment
of some infections. First, it is interesting to remark that the less polar flower extracts (hexane,
dichloromethane) showed very strong antibacterial activity against methicillin-sensitive S. aureus
ATCC 25923 and methicillin-sensitive S. aureus ATCC 43300. Additionally, the hexane extract showed
activity against K. pneumoniae, while the methanol extract from the fruits was also active against the
three strains mentioned above. Such activity might be explained at least in part by the content of the
new main compound (R)-2-(4-methylcyclohex-3-en-1-yl)propan-2-yl (E)-3-(4-hydroxyphenyl)acrylate
(1). This compound showed strong antimicrobial activity against all Gram (+) species tested. The
demand for new antibacterial agents and the new trend towards the use of characterized natural
extracts or compounds isolated as medicines instead of pure drugs might open an alternative way for
the development of new antibacterial agents, trying to avoid the serious problem of resistance to the
antibiotics in use today. On the other hand, the molecular calculations allowed for the establishment
of structure-activity relationships between the antibacterial compounds reported here, which gives
important information about a possible pharmacophoric pattern of these compounds. This information
may be of great interest for the search and procurement of new structurally related antibacterial agents.
Supplementary Materials: The Supplementary materials are available online.
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